HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows

BACKGROUND: Primary high risk (hr)HPV screening will be introduced in The Netherlands in January 2017. Our aim was to determine the hrHPV prevalence in the Dutch cervical cancer screening population (DuSC study). METHODS: A total of 12,113 residual PreservCyt cervical samples from the Dutch populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huijsmans, Cornelis Johannes Jacobus, Geurts-Giele, Willemina Rosalia Rita, Leeijen, Cindy, Hazenberg, Hendrikus Lambertus Cornelius Maria, van Beek, Jenneke, de Wild, Carola, van der Linden, Johannes Cornelis, van den Brule, Adrianus Johannes Christiaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127037/
https://www.ncbi.nlm.nih.gov/pubmed/27894291
http://dx.doi.org/10.1186/s12885-016-2961-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127037/
https://www.ncbi.nlm.nih.gov/pubmed/27894291
http://dx.doi.org/10.1186/s12885-016-2961-2

Ejemplares similares